About
We aim to unravel pathophysiology, identify therapeutic targets, discover biomarkers and develop (gene) therapies by studying rare glomerular and tubular kidney disorders. We integrate cell-based assays, kidney-on-a-chip and in vivo models with patient materials and clinically evaluate new treatment options.
Research group leader
prof. dr. Tom Nijenhuis
Research programs
Programs that are connected to this research group.